ArticleFrontiers in immunology2021

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis.

Ying He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.